TrialJournal of hematology & oncology2017

Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study.

Rui-Hua Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.